您查看的活动已结束

10月21日（周三），深圳健谈会、平安科技创新中心、英国国际贸易部, L.E.K.和广东英国商会将共同举办一场主题为“人工智能在中国健康行业的机遇与挑战”的座谈会活动. 南方医学网是本次活动的直播合作伙伴。

艾意凯咨询大中华区主管合伙人陈玮将主持本次圆桌会议，出席嘉宾包括：

• 杨昊臻 – 腾讯总经理及首席医疗顾问

• 章桦 - 连心医疗CEO

• 苏小凡 -  裕策生物裕泰抗原事业部总经理

• 邱博大 – Holmusk赫尔马科技大中华区商务总监

• 陈思 – Huma商务拓展总监

人工智能和大数据正改变着现代医疗健康，随之而来的机遇是前所未有的。然而，在充分利用这项技术带来的机会之前（入改善癌症诊断和降低风险药物开发风险），仍面临这一些关键挑战，如患者对隐私的担忧以及医生不愿意适应新技术的发展。

On Wednesday, October 21st from 6:30 p.m. to 9:00 p.m., Shenzhen Healthcare Drinks, Ping An Technology Innovation Center, the UK Department of International Trade, L.E.K., the British Chamber of Commerce and Edinburgh International will hold after work discussion panel entitled “Challenges and Opportunities for Healthcare AI in China”. Southmed Healthcare Network is the online broadcasting partner. 

  
The panel will be moderated by Helen Chen, Greater China Managing Partner, L.E.K. Consulting and consist of the following executives:
​
• Haozhen Yang – GM, Chief Medical Consultant, Tencent
• Ryan Zhang – CEO, LinkingMed 
• Ernest Su – Yuce Bio Yutai Antigen Division General Manager, Yuce Bio
​• Eason Qiu – Holmusk, Director of Business Development Greater China
• Echo Chen – BD Director, Huma

AI and Big Data are transforming modern healthcare and the opportunities are unprecedented. However, key challenges like privacy concerns and doctor’s aversion to new technology need to be overcome in order for opportunities like improving cancer diagnosis, de-risking drug development can be fully leveraged.